Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: From the Master Agreement... PDS can be sold...
2
Nov 02, 2007 02:23PM

From your post-

TPL is authorized to act on behalf of the parties pursuant to the Commercialization Agreement and the Grant referred to therein, including, but not limited to, contacting, pursuing litigation against, or entering into discussions or negotiations with potential infringers, entering into license agreements, settlement agreements, or other similar agreements with respect to the MSD Patents,or selling or otherwise transferring any interest in the MSD Patents

Just read the Commercialization Agreement it contains nothing pertaining to TPL or any other entity authorizing a sale of either T-Newco or P-Newco (now PDS).

There may be buyout someday but it won't happen through PDS alone. Corrections welcome.

1
Nov 02, 2007 05:34PM
1
Nov 02, 2007 05:43PM

Nov 02, 2007 06:05PM
Share
New Message
Please login to post a reply